690
Views
6
CrossRef citations to date
0
Altmetric
Invited Commentary

Failure of a Meta-analysis: A Commentary on Glen Spielmans’s “Re-Analyzing Phase III Bremelanotide Trials for ‘Hypoactive Sexual Desire Disorder in Women’”

, , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anders Ågmo & Ellen Laan. (2023) The Sexual Incentive Motivation Model and Its Clinical Applications. The Journal of Sex Research 60:7, pages 969-988.
Read now
Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani & Barbara Gardella. (2023) Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?. Expert Opinion on Pharmacotherapy 24:1, pages 135-143.
Read now
Glen I. Spielmans. (2021) Irrelevancies and Inaccuracies Miss the Target: A Response to Kingsberg et al.. The Journal of Sex Research 58:9, pages 1108-1111.
Read now

Articles from other publishers (3)

James G. Pfaus. (2022) The Cancer of Cancel Culture: Spreading “Correct” Scientific Ideologies Across North American Academia. Archives of Sexual Behavior 52:1, pages 43-47.
Crossref
Elisa Ventura-Aquino & Anders Ågmo. 2023. Animal Models of Reproductive Behavior. Animal Models of Reproductive Behavior 299 312 .
Scott Yaekle, Halima Ali & Carol Baker. (2021) There is insufficient evidence to recommend bremelanotide for hypoactive sexual desire disorder. Clinical Research In Practice: The Journal of Team Hippocrates 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.